
Numsa investment co. plans to bring drugs from India, Russia to fight Covid-19 - Tim Modise interviews Khandani Msibi
Loading player...
In this interview with broadcaster Tim Modise, Khandani Msibi, CEO of Numsa Investment Company, talks about 3sixtyBiomedicine’s offering hope in fighting Covid19 by bringing Covid19 therapies Remdesevir from India and from Russia Avifavir to South Africa. He says the medications are likely to be made available in the country in two weeks. He also talks about the PPE-related corruption and the lost opportunity to empower black-owned businesses. Learn more about your ad choices. Visit megaphone.fm/adchoices





